Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -1.54 is 26% above its 5-year average of -2.08, around the middle of its 5-year range (-4.12–0.13).
44.80% above its 12-month average of -2.79.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.39.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 40 comparable quarters.
FMP quote price / unrounded diluted EPS from four consecutive issuer fiscal quarters Quote observation: 2026-10-06T18:22:24.804Z. Historical observations retain their original dates. Historical series through 2021-04-30.
EARNINGS PER SHARE (EPS)
-1.54
EARNINGS PER SHARE (EPS) AVG TTM
-2.79
EARNINGS PER SHARE (EPS) AVG 3Y
-2.67
EARNINGS PER SHARE (EPS) AVG 5Y
-2.08
EARNINGS PER SHARE (EPS) AVG 10Y
-1.17
EARNINGS PER SHARE (EPS) AVG 15Y
-0.61
EARNINGS PER SHARE (EPS) AVG 20Y
-0.43
CURRENT VS TTM AVG
+44.80%
CURRENT VS 3Y AVG
+42.32%
CURRENT VS 5Y AVG
+26.08%
CURRENT VS 10Y AVG
-31.32%
CURRENT VS 15Y AVG
-153.27%
CURRENT VS 20Y AVG
-262.18%
Orthofix Medical Inc.
Market Cap
$384.31M
Earnings Per Share (EPS)
-1.54
TTM Avg
-2.79
3Y Avg
-2.67
5Y Avg
-2.08
Market Cap
$384.27M
Earnings Per Share (EPS)
-1.13
TTM Avg
-1.34
3Y Avg
-1.04
5Y Avg
-1.04
Market Cap
$377.54M
Earnings Per Share (EPS)
-2.94
TTM Avg
-3.49
3Y Avg
-2.70
5Y Avg
-2.28
Market Cap
$376.11M
Earnings Per Share (EPS)
N/A
TTM Avg
-0.34
3Y Avg
-0.07
5Y Avg
0.03
Market Cap
$377.17M
Earnings Per Share (EPS)
-3.33
TTM Avg
-2.70
3Y Avg
-1.54
5Y Avg
-2.91
Market Cap
$393.16M
Earnings Per Share (EPS)
-3.79
TTM Avg
-4.17
3Y Avg
-5.22
5Y Avg
-3.47
Market Cap
$375.42M
Earnings Per Share (EPS)
-0.50
TTM Avg
-5.17
3Y Avg
-17.19
5Y Avg
-12.52
Market Cap
$403.51M
Earnings Per Share (EPS)
-2.08
TTM Avg
-1.97
3Y Avg
-1.74
5Y Avg
-0.94
Market Cap
$404.24M
Earnings Per Share (EPS)
-1.36
TTM Avg
-1.81
3Y Avg
-2.62
5Y Avg
-2.62
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Orthofix Medical Inc. (OFIX) | $384.31M | -1.54 | -2.79 | -2.67 | -2.08 |
| Zura Bio Limited (ZURA)vs › | $384.27M | -1.13 | -1.34 | -1.04 | -1.04 |
| Kyverna Therapeutics, Inc. (KYTX)vs › | $377.54M | -2.94 | -3.49 | -2.70 | -2.28 |
| YD Bio Limited Ordinary Shares (YDES)vs › | $376.11M | N/A | -0.34 | -0.07 | 0.03 |
| Arcturus Therapeutics Holdings Inc. (ARCT)vs › | $377.17M | -3.33 | -2.70 | -1.54 | -2.91 |
| REGENXBIO Inc. (RGNX)vs › | $393.16M | -3.79 | -4.17 | -5.22 | -3.47 |
| Canopy Growth Corporation (CGC)vs › | $375.42M | -0.50 | -5.17 | -17.19 | -12.52 |
| Atea Pharmaceuticals, Inc. (AVIR)vs › | $403.51M | -2.08 | -1.97 | -1.74 | -0.94 |
| Carlsmed, Inc. (CARL)vs › | $404.24M | -1.36 | -1.81 | -2.62 | -2.62 |
| Opus Genetics, Inc. (IRD)vs › | $363.51M | N/A | -1.30 | -1.38 | -1.95 |
Trailing EPS (TTM)
$-1.54
Forward EPS (Est.)
$-1.17
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -2.28 |
| 2024-12-31 | -3.30 |
| 2023-12-31 | -4.12 |
| 2022-12-31 | -0.98 |
| 2021-12-31 | -1.95 |
| 2020-12-31 | 0.13 |
| 2019-12-31 | -1.51 |
| 2018-12-31 | 0.75 |
| 2017-12-31 | 0.34 |
| 2016-12-31 | 0.17 |
| 2015-12-31 | -0.15 |
| 2014-12-31 | -0.46 |
| 2013-12-31 | -1.52 |
| 2012-12-31 | 2.70 |
| 2011-12-31 | -0.06 |
| 2010-12-31 | 2.51 |
| 2009-12-31 | 1.43 |
| 2008-12-31 | -13.37 |
| 2007-12-31 | 0.66 |
| 2006-12-31 | -0.44 |
| 2005-12-31 | 4.61 |
| 2004-12-31 | 2.22 |
| 2003-12-31 | 1.76 |
| 2002-12-31 | 1.96 |
| 2001-12-31 | 1.60 |
| 2000-12-31 | 3.40 |
| 1999-12-31 | 0.99 |
| 1998-12-31 | 1.10 |
| 1997-12-31 | 0.24 |
| 1996-12-31 | -0.04 |
(FMP quote price / unrounded diluted TTM EPS) / five-year diluted EPS CAGR in percent, from annual statements through the period end shown Quote observation: 2026-10-06T18:22:24.804Z. Historical observations retain their original dates. Historical series through 2014-03-31.
